PITTSBURGH, March 21 /PRNewswire-FirstCall/ -- Mylan Laboratories Inc. announced today that the regular quarterly cash dividend of $.06 per share will be payable on April 17, 2006, to shareholders of record at the close of business on March 31, 2006.
Mylan Laboratories Inc. is a leading pharmaceutical company with three principal subsidiaries, Mylan Pharmaceuticals Inc., Mylan Technologies Inc. and UDL Laboratories, Inc., that develop, license, manufacture, market and distribute an extensive line of generic and proprietary products.
For more information about Mylan, visit www.mylan.com.
Mylan Laboratories Inc.CONTACT: Patrick Fitzgerald or Kris King of Mylan Laboratories Inc.,+1-724-514-1800
Web site: http://www.mylan.com//
